Stock Events

Stock Events

Relmada Therapeutics (4E2.F) Q2 2026 Earnings

4E2.F
May 12Confirmed
Q2 2025
Q3 2025
Q4 2025
Q2 2026
-0.52
-0.41
-0.29
-0.17

Details

Expected EPS
-0.1706876766
Actual EPS
-0.18743780000000002
Surprise EPS
-0.02
Surprise Percent
-9.81%

Description

⁨Relmada Therapeutics⁩ (⁦4E2.F⁩) has reported earnings of ⁦-0.18743780000000002⁩ per share for ⁦Q2 2026⁩.

0 Comments

Share your thoughts